Wendy B. Young - Director at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
RAPP on Nasdaq
All Insider Reports
All Insider Reports

Wendy B. Young - trading volume in the past year for Rapport Therapeutics, Inc.

Holdings reported by Wendy B. Young for Rapport Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 9,500 $214,700 $22.60 11 Sep 2025 Direct
Stock Option (Right to Buy) 10,925 17 Jun 2025 Direct Common Stock

Transactions reported by Wendy B. Young for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.